Paul Gregorevic

Paul Gregorevic

The University of Melbourne
在 unimelb.edu.au 的电子邮件经过验证
被引用次数：11207
Skeletal muscle biology Follistatin BMP Hippo signalling AAV gene therapy
Paul Morin

Paul Morin

Director and Research Fellow Bristol Myers Squib
在 bms.com 的电子邮件经过验证
被引用次数：3841
AAV gene therapy protein engineering tropism interleukins
Miles J De Blasio

Miles J De Blasio

Monash University, Melbourne Australia
在 monash.edu 的电子邮件经过验证
被引用次数：3297
Cardiomyopathy T2D Adiponectin AAV Gene Therapy Cardiac metabolism.
Nicole K. Paulk, PhD

Nicole K. Paulk, PhD

CEO, Siren Biotechnology
在 sirenbiotechnology.com 的电子邮件经过验证
被引用次数：2318
AAV Gene Therapy Immunotherapy Oncology
Adam Washburn

Adam Washburn

Eli Lilly and Company
在 lilly.com 的电子邮件经过验证
被引用次数：1535
AAV Gene Therapy Monoclonal Antibodies Drug Development
Hassibullah Akeefe

Hassibullah Akeefe

被引用次数：1119
AAV Gene Therapy
Bryan P. Simpson, PhD

Bryan P. Simpson, PhD

University of Pennsylvania
在 pennmedicine.upenn.edu 的电子邮件经过验证
被引用次数：984
AAV Gene Therapy CRISPR/Cas9 Long-read sequencing Neurodegenerative diseases Bioinformatics
RANJAN DAS

RANJAN DAS

Staff Scientist at Oregon Health & Science University, Portland, OR
在 ohsu.edu 的电子邮件经过验证
被引用次数：657
Kidney Diseases AAV Gene Therapy Capsid Engineering Genomics CRISPR/Cas9
Ulisse Ferrari

Ulisse Ferrari

CRNS tenured, Institut de la Vision
在 inserm.fr 的电子邮件经过验证
被引用次数：639
Computational neuroscience AAV gene therapy Statistical physics
Acacia Mayfield

Acacia Mayfield

Graduate Student, USC-Caltech MD-PhD Program
被引用次数：616
AAV gene therapy rare diseases neurodevelopment neurodegeneration
1 - 10